Digestive system carcinoma
MONDO:0006181A malignant neoplasm that arises from the epithelium of any part of the digestive system. Representative examples include colorectal carcinoma, esophageal carcinoma, and pancreatic carcinoma.
Also known as: carcinoma of digestive system, carcinoma of the gastrointestinal system, digestive system carcinoma, gastrointestinal carcinoma, gastrointestinal carcinoma (disease), gastrointestinal system carcinoma
7486 clinical trials for this condition and its sub-types, 25 tagged with Digestive system carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Digestive system carcinoma
-
Carcinoma of liver and intrahepatic biliary tract 36 trials · 1,455 incl. sub-types
7 sub-types
- Hepatocellular carcinoma 1,043 trials · 1,088 incl. sub-types Sub-types →
- Bile duct carcinoma 20 trials · 451 incl. sub-types Sub-types →
- Liver neuroendocrine carcinoma 3 trials Sub-types →
- Undifferentiated carcinoma of liver and intrahepatic biliary tract 1 trial
- Biliary cystadenocarcinoma 0 trials
- Liver carcinoma in situ 0 trials Sub-types →
- Squamous cell carcinoma of liver and intrahepatic biliary tract 0 trials Sub-types →
-
Colorectal carcinoma 305 trials · 1,166 incl. sub-types
4 sub-types
- Colorectal adenocarcinoma 246 trials · 546 incl. sub-types Sub-types →
- Rectal carcinoma 54 trials · 392 incl. sub-types Sub-types →
- Colon carcinoma 277 trials · 377 incl. sub-types Sub-types →
- Colorectal squamous cell carcinoma 1 trial · 54 incl. sub-types Sub-types →
-
Exocrine pancreatic carcinoma 205 trials · 1,033 incl. sub-types
8 sub-types
- Pancreatic adenocarcinoma 493 trials · 926 incl. sub-types Sub-types →
- Squamous cell carcinoma of pancreas 3 trials · 13 incl. sub-types Sub-types →
- Familial pancreatic carcinoma 9 trials
- Pancreatic carcinoma with mixed differentiation 3 trials
- Pancreatic intraductal papillary-mucinous carcinoma 0 trials · 2 incl. sub-types Sub-types →
- Pancreatic mucinous cystadenoma 1 trial
- Pancreatic large cell neuroendocrine carcinoma 0 trials
- Solid pseudopapillary carcinoma of pancreas 0 trials
-
Gastric carcinoma 92 trials · 554 incl. sub-types
12 sub-types
- Gastric adenocarcinoma 448 trials · 480 incl. sub-types Sub-types →
- Gastric cardia carcinoma 3 trials · 7 incl. sub-types Sub-types →
- Hereditary gastric cancer 1 trial · 6 incl. sub-types Sub-types →
- Gastric squamous cell carcinoma 4 trials Sub-types →
- Stomach carcinoma in situ 4 trials Sub-types →
- Epstein-Barr virus-associated gastric carcinoma 1 trial
- Gastric body carcinoma 1 trial Sub-types →
- Undifferentiated carcinoma of stomach 1 trial
- Carcinoma of stomach, salivary gland type 0 trials
- Gastric fundus carcinoma 0 trials Sub-types →
- Gastric pylorus carcinoma 0 trials
- Gastric small cell neuroendocrine carcinoma 0 trials
-
Gastroesophageal junction adenocarcinoma 506 trials
-
Carcinoma of esophagus 75 trials · 504 incl. sub-types
5 sub-types
- Esophageal squamous cell carcinoma 303 trials · 304 incl. sub-types Sub-types →
- Esophageal adenocarcinoma 168 trials · 172 incl. sub-types Sub-types →
- Esophagus carcinoma in situ 13 trials
- Esophageal small cell neuroendocrine carcinoma 2 trials
- Carcinoma of esophagus, salivary gland type 0 trials
-
Carcinoma of pharynx 3 trials · 455 incl. sub-types
6 sub-types
- Oropharyngeal carcinoma 99 trials · 242 incl. sub-types Sub-types →
- Nasopharyngeal carcinoma 210 trials · 211 incl. sub-types Sub-types →
- Pharyngeal squamous cell carcinoma 5 trials · 203 incl. sub-types Sub-types →
- Hypopharyngeal carcinoma 35 trials · 86 incl. sub-types Sub-types →
- Pharynx carcinoma in situ 0 trials · 2 incl. sub-types Sub-types →
- Pharyngeal adenoid cystic carcinoma 0 trials
-
Oral cavity carcinoma 16 trials · 200 incl. sub-types
9 sub-types
- Oral cavity squamous cell carcinoma 139 trials · 154 incl. sub-types Sub-types →
- Salivary gland carcinoma 26 trials · 36 incl. sub-types Sub-types →
- Oral cavity carcinoma in situ 5 trials Sub-types →
- Tongue carcinoma 4 trials
- Carcinoma of lip 0 trials · 2 incl. sub-types Sub-types →
- Carcinoma of hard palate 1 trial
- Carcinoma of soft palate 1 trial
- Intraoral basal cell carcinoma 0 trials
- Oral cavity mucoepidermoid carcinoma 0 trials Sub-types →
-
Small intestine carcinoma 19 trials · 105 incl. sub-types
3 sub-types
- Carcinoma of duodenum 21 trials · 75 incl. sub-types Sub-types →
- Small intestine adenocarcinoma 18 trials · 60 incl. sub-types Sub-types →
- Squamous cell carcinoma of the small intestine 1 trial Sub-types →
-
Gallbladder carcinoma 40 trials · 48 incl. sub-types
5 sub-types
- Gallbladder adenocarcinoma 9 trials Sub-types →
- Gall bladder carcinoma in situ 0 trials
- Gallbladder small cell neuroendocrine carcinoma 0 trials
- Gallbladder squamous cell carcinoma 0 trials Sub-types →
- Undifferentiated gallbladder carcinoma 0 trials
-
Intestine carcinoma in situ 0 trials · 16 incl. sub-types
2 sub-types
- Rectum carcinoma in situ 1 trial · 13 incl. sub-types Sub-types →
- Colon carcinoma in situ 3 trials Sub-types →
-
Pancreatic endocrine carcinoma 12 trials
2 sub-types
-
Digestive system mixed adenoneuroendocrine carcinoma 0 trials · 3 incl. sub-types
1 sub-type
-
Carcinoma of floor of mouth 1 trial · 2 incl. sub-types
2 sub-types
-
Maxillary sinus carcinoma 1 trial · 2 incl. sub-types
3 sub-types
- Maxillary sinus squamous cell carcinoma 1 trial
- Maxillary sinus adenocarcinoma 0 trials
- Maxillary sinus adenoid cystic carcinoma 0 trials
-
Ameloblastic carcinoma 0 trials
Most studied deeper sub-types
-
Experimental drug put to the test against Hard-to-Treat GI cancers
Disease control Not yet recruitingResearchers are testing an experimental injectable drug called ALK-N001 in adults with advanced gastrointestinal tumors, including esophageal and colorectal cancers that have worsened after standard treatment. The phase II trial gives the drug intravenously every two weeks at one…
Phase 2 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a Patient's own immune cells be trained to fight advanced GI cancers?
Disease control Not yet recruitingThis early trial is testing an experimental cell therapy called cCTL-GL01 in people with advanced stomach, esophageal, colon, or rectal cancers that have not responded to standard treatments. The therapy uses a patient's own immune cells, which are specially trained in the lab to…
Phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC